The Valley Desk

Clinical trial reportClinical breast cancerPublished

A Phase II Trial of Onapristone and Fulvestrant for Patients With ER+ and HER2- Metastatic Breast Cancer

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Thomas Jefferson University. Affiliation source

Publication record

Type
Clinical trial report
Venue
Clinical breast cancer
Published
Subject terms
Humans; Breast Neoplasms; Receptors, Estrogen; Receptors, Progesterone; Antineoplastic Combined Chemotherapy Protocols; Adult; Aged; Middle Aged; Female; Positron Emission Tomography Computed Tomography; Fulvestrant; Erb-b2 Receptor Tyrosine Kinases
PubMed ID
39824712
Added to directory
Source checked

Report a correction or request removal